Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’ Imfinzi fails in head and neck cancer trial

pharmatimesDecember 10, 2018

Tag: AstraZeneca , Imfinzi , MedImmune

PharmaSources Customer Service